Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

NCT03971461 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

NYU Langone Health